Theradiag S.A. buy krebskrebs
Start price
16.08.21
/
50%
€1.90
Target price
16.08.22
€2.40
Performance (%)
-14.53%
End price
17.08.22
€1.62
Summary
This prediction ended on 17.08.22 with a price of €1.62. The prediction for Theradiag S.A. disappointed with a performance of -14.53%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Theradiag S.A. | - | - | - | - |
| iShares Core DAX® | 3.593% | 6.427% | 15.378% | 52.309% |
| iShares Nasdaq 100 | 5.810% | 6.381% | 41.455% | 91.771% |
| iShares Nikkei 225® | 4.075% | 9.307% | 48.947% | 65.859% |
| iShares S&P 500 | 4.142% | 4.938% | 31.594% | 65.326% |
Comments by krebskrebs for this prediction
In the thread Theradiag S.A. diskutieren
In the thread Trading Theradiag S.A.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten